SEC Form 4 · accession 0001209191-15-060805
HUMANIGEN, INC · HGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ted W Love
Director
Period of report
Jul 10, 2015
Accepted (ET)
Jul 14, 2015 · 4:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293310
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $3.68 | Jul 10, 2015 | A | 5,000 | A | — | Jul 9, 2025 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1The amount of shares covered by this option was 40,000 with an exercise price of $0.46 upon date of grant but subsequently subject to a 1 for 8 reverse stock split on July 13, 2015.
- F2The option shares will vest and become exercisable ratably over 12 months of continuous service after July 10, 2015, subject to the terms of the Company's 2012 Equity Incentive Plan.